Iboxx $ High Yield Corporate Bd Ishares (HYG) 85.11

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Iboxx $ High Yield Corporate Bd Ishares (HYG) 85.11 $HYG

Look for Shares of iShares iBoxx $ High Yield Corporate Bond to Potentially Pullback after Yesterday's 1.20% Rise
Comtex SmarTrend(R) - Mon Oct 05, 3:54PM CDT
iShares iBoxx $ High Yield Corporate Bond (AMEX:HYG) traded in a range yesterday that spanned from a low of $82.81 to a high of $83.47. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $83.34 on volume of 12.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HYG: 85.11 (+0.01)

After Yesterday's Rally of 1.20% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Oct 05, 3:53PM CDT
iShares iBoxx $ High Yield Corporate Bond (AMEX:HYG) traded in a range yesterday that spanned from a low of $82.81 to a high of $83.47. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $83.34 on volume of 12.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HYG: 85.11 (+0.01)

The Trader Daily: Err on the Side of Buying Dips
at The Street - Mon Oct 05, 6:00AM CDT
As long as the Es continue to close of its shortest EMAs.
HYG: 85.11 (+0.01), TLT: 122.28 (+0.32)

Trader's Notebook: On Biotech, I'd Rather Sit on the Sidelines
at The Street - Tue Sep 29, 8:00AM CDT
I'll let the market tell me when the trend is turning bullish.
JNK: 36.31 (+0.01), HYG: 85.11 (+0.01), IBB: 308.45 (+1.25)

'Fast Money' Recap: Get Your Bargain-Stock Buying List Ready
at The Street - Tue Sep 29, 4:00AM CDT
The trading panel discussed biotech stocks, Glencore and Apple's iPhone sales weekend.
SBUX: 60.07 (+0.61), HYG: 85.11 (+0.01), HD: 121.33 (+0.27), SPY: 201.33 (+0.12), NKE: 124.94 (+0.03), GILD: 100.65 (-0.16), IBB: 308.45 (+1.25), IWM: 115.74 (+0.23), AAPL: 112.12 (+2.62)

SmarTrend Watching for Potential Rebound in Shares of iShares iBoxx $ High Yield Corporate Bond After 1.53% Loss
Comtex SmarTrend(R) - Mon Sep 28, 4:02PM CDT
iShares iBoxx $ High Yield Corporate Bond (AMEX:HYG) traded in a range yesterday that spanned from a low of $82.72 to a high of $84.02. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $84.04 on volume of 12.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HYG: 85.11 (+0.01)

iShares iBoxx $ High Yield Corporate Bond Set to Possibly Rebound After Yesterday's Selloff of 1.53%
Comtex SmarTrend(R) - Mon Sep 28, 4:01PM CDT
iShares iBoxx $ High Yield Corporate Bond (AMEX:HYG) traded in a range yesterday that spanned from a low of $82.72 to a high of $84.02. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $84.04 on volume of 12.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HYG: 85.11 (+0.01)

Here's Why Actively Managed High-Yield Bond Funds Beat ETFs
at The Street - Fri Sep 18, 4:14PM CDT
Investors have poured nearly $9 billion into high-yield exchange traded funds since 2013 began. They'd have made more money with high-yield bonds, says Gershon Distenfeld, AllianceBernstein director of high yield.
JNK: 36.31 (+0.01), HYG: 85.11 (+0.01), AWF: 11.34 (+0.07)

Don't Look for a Hign Yield Rally Anytime Soon
at The Street - Thu Sep 17, 1:14PM CDT
The iShares High Yield Corporate Bond ETF has been declining for most of this year, and its technicals are weak. Any rally would be temporary.
HYG: 85.11 (+0.01)

High Yield Going Back to the Junkyard
at The Street - Thu Sep 17, 12:44PM CDT
The iShares High Yield Corporate Bond ETF has been declining for most of this year, and its technicals are weak. Any rally would be temporary.
HYG: 85.11 (+0.01)

What to Buy in a 'Paused' Market: Europe, High-Yield, Tech Stocks
at The Street - Wed Sep 16, 5:43PM CDT
Here are some picks from Luca Paolini, chief strategist at Pictet Asset Management.
JNK: 36.31 (+0.01), HYG: 85.11 (+0.01), EEM: 35.94 (+0.13)

Watch These Income ETFs as Fed Meets
Sweta Killa - Zacks Investment Research - Wed Sep 16, 10:15AM CDT
Income-investing corner of the world could see heavy trading post Fed meeting.
JNK: 36.31 (+0.01), HYG: 85.11 (+0.01), DVY: 75.95 (-0.07), MORT: 20.99 (-0.04), REM: 10.38 (-0.02), VIG: 77.38 (+0.14), VPU: 94.61 (-0.33), XLU: 43.79 (-0.21), SDY: 75.65 (-0.13)

Noteworthy ETF Inflows: HYG
ETFChannel.com - Mon Aug 31, 9:58AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares iBoxx $ High Yield Corporate Bond ETF where we have detected an approximate $248.1 million dollar inflow --...
HYG: 85.11 (+0.01)

More Evidence of the Coming Market Crash: Junk Bonds Headed for Fall
at The Street - Mon Aug 17, 8:52AM CDT
A look at the technical charts shows junk bonds at levels that presage the fall to come. Here's how to manage the downturn of this asset.
HYG: 85.11 (+0.01)

Why ETFs Are the Preferred Avenue for Accessing Junk Bonds
at The Street - Tue Aug 04, 5:20AM CDT
Billionaire investor Carl Icahn has been warning that the high-yield debt market is a bubble that could burst any time. ETFs could be an alternate way to invest.
JNK: 36.31 (+0.01), HYG: 85.11 (+0.01), AGG: 109.33 (-0.09)

Icahn't Believe Icahn's Junk-Bond Remarks
at The Street - Mon Jul 27, 12:00PM CDT
Activist investor's criticism of high-yield-bond ETFs is misplaced.
HYG: 85.11 (+0.01), BLK: 318.11 (-0.46)

The Trader Daily: Don't Get Caught Up in Everything That Could Go Wrong
at The Street - Thu Jul 23, 6:00AM CDT
Try to follow a basic, easy-to-understand model.
JNK: 36.31 (+0.01), GPRO: 29.08 (+1.48), HYG: 85.11 (+0.01), SPY: 201.33 (+0.12), MSFT: 47.11 (-0.34), TLT: 122.28 (+0.32), AAPL: 112.12 (+2.62)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading